In a phase III trial of 290 patients with advanced pancreatic cancer on standard care, subcutaneous mistletoe extract did not improve quality of life or weight versus placebo; supportive care use and biomarkers were similar, apart from raised eosinophils.
RCTn = 290
Wode et al. Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, randomized, placebo-controlled trial (MISTRAL)